P43405 (KSYK_HUMAN) Homo sapiens (Human)
Tyrosine-protein kinase SYK UniProtKBInterProSTRINGInteractive Modelling
635 aa; Sequence (Fasta) ; (Isoform 2)
Available Structures
90 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| The tandem SH2 domains of SYK with a bound CD3G diphospho-ITAM peptide |
Heteromer P09693; | 100 | 2×EDO; 1×PEG; 1×P4G; | |||
| The tandem SH2 domains of SYK with a bound FCER1G diphospho-ITAM peptide |
Heteromer P30273; | 100 | 2×PO4; 1×EDO; | |||
| The tandem SH2 domains of SYK with a bound TYROBP diphospho-ITAM peptide |
Heteromer O43914; | 100 | 1×PO4; 1×EDO; | |||
| CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLA… |
Heteromer P07766; | 100.0 | ||||
| Crystal structure of c-Cbl-TKB domain complexed with its binding motif in Syk |
Heteromer P22681; | 100 | ||||
| Crystal structure of Syk catalytic domain in complex with a furo[3,2-d]pyrimidine | homo-2-mer | 100.0 | 2×77V; | |||
| Crystal structure of spleen tyrosine kinase (SYK) in complex with SKI-O-592 (free form of SKI-O-703… | homo-2-mer | 100.0 | 2×XFB; 1×GOL; | |||
| Structural and Biophysical Characterization of the Syk Activation Switch | monomer | 99.63 | 1×ANP; 1×MG; | |||
| Structural and Biophysical Characterization of the Syk Activation Switch | monomer | 100.0 | 1×MG; 1×ANP; | |||
| SYK catalytic domain in complex with a potent triazolopyridine inhibitor | monomer | 100.0 | 1×3RT; 1×SO4; | |||
| Discovery of TAK-659, an Orally Available Investigational Inhibitor of Spleen Tyrosine Kinase (SYK) | monomer | 100.0 | 1×7KF; | |||
| SYK catalytic domain complexed with a potent and orally bioavailable benzisothiazole inhibitor | monomer | 99.64 | 1×55Y; | |||
| Crystal structure of SYK kinase domain with 1-benzyl-N-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-… | monomer | 100.0 | 1×FPW; | |||
| Discovery of TAK-659, an Orally Available Investigational Inhibitor of Spleen Tyrosine Kinase (SYK) | monomer | 100.0 | 1×7KG; 1×EDO; | |||
| Crystal structure of spleen tyrosine kinase complexed with N-{(S)-1-[7-(3,4-Dimethoxy-phenylamino)-… | monomer | 100.0 | 1×0VF; | |||
| SYK Kinase domain in complex with azabenzimidazole inhibitor 3 | monomer | 100.0 | 1×QFE; | |||
| Crystal structure of SYK kinase domain with inhibitor | monomer | 100.0 | 1×7CU; | |||
| Syk kinase domain in complex with macrocyclic inhibitor 20a | monomer | 100.0 | 1×QR7; | |||
| Crystal structure of the syk tyrosine kinase domain with Gleevec | monomer | 100.0 | 1×STI; | |||
| SYK Kinase domain in complex with azabenzimidazole inhibitor 18 | monomer | 100.0 | 1×QFQ; | |||
| Crystal structure of spleen tyrosine kinase complexed with 2-(5,6,7,8-Tetrahydro-imidazo[1,5-a]pyri… | monomer | 100.0 | 1×1B6; | |||
| SYK catalytic domain complexed with naphthyridine inhibitor | monomer | 99.62 | 1×GOL; 1×CL; 1×55U; | |||
| syk in complex with 57262_SYKB-AZ13344324-2 | monomer | 100.0 | 1×5JG; | |||
| SYK Kinase domain in complex with azabenzimidazole inhibitor 7 | monomer | 100.0 | 1×5JG; | |||
| Crystal structure of spleen tyrosine kinase complexed with 6-((1R,2S)-2-Amino-cyclohexylamino)-4-(6… | monomer | 100.0 | 1×0VH; | |||
| SYK Catalytic Domain Complexed with a Potent Pyrimidine Inhibitor | monomer | 99.62 | 1×GOL; 1×3YT; | |||
| Structural and Biophysical Characterization of the Syk Activation Switch | monomer | 100.0 | 1×ANP; 1×MG; | |||
| SYK Catalytic Domain Complexed with a Potent Triazine Inhibitor | monomer | 99.63 | 1×FMT; 1×GOL; 1×3YV; | |||
| Crystal structures of spleen tyrosine kinase in complex with a novel inhibitor | monomer | 100.0 | 1×8OR; | |||
| SYK Kinase domain in complex with diamine inhibitor 16 | monomer | 100.0 | 1×QF8; | |||
| Crystal structure of spleen tyrosine kinase complexed with [6-((S)-2-Methyl-pyrrolidin-1-yl)-pyridi… | monomer | 100.0 | 1×0VG; | |||
| SYK catalytic domain complexed with a potent orally bioavailable thiazole inhibitor | monomer | 99.63 | 1×55M; | |||
| Crystal structure of SYK in complex with compound 1 | monomer | 100 | 1×50H; | |||
| SYK Kinase domain in complex with azabenzimidazole inhibitor 2b | monomer | 100.0 | 1×QDZ; | |||
| Crystal structure of spleen tyrosine kinase complexed with 2-(6-Chloro-1-methyl-1H-indazol-3-yl)-5H… | monomer | 100.0 | 1×1B5; | |||
| Crystal structure of spleen tyrosine kinase complexed with a sulfonamidopyrazine piperidine inhibit… | monomer | 100.0 | 1×0K0; 1×EDO; 1×SO4; | |||
| Crystal structure of apo syk tyrosine kinase domain | monomer | 100.0 | ||||
| Crystal structure of the syk tyrosine kinase domain with Staurosporin | monomer | 100.0 | 1×STU; | |||
| Crystal structure of spleen tyrosine kinase (Syk) in complex with an imidazopyrazine inhibitor | monomer | 100.0 | 1×CG4; 5×CL; | |||
| Crystal Structure of Spleen Tyrosine Kinase Syk Catalytic Domain with Pyrazolylbenzimidazole Inhibi… | monomer | 100.0 | 1×0JE; | |||
| syk in complex with compound 30 | monomer | 100.0 | 1×LUE; | |||
| Crystal structure of spleen tyrosine kinase complexed with R406 | monomer | 100.0 | 1×585; | |||
| Crystal structure of spleen tyrosine kinase complexed with 2-(3,4,5-Trimethoxy-phenyl)-5H-pyrrolo[2… | monomer | 100.0 | 1×1B4; | |||
| Crystal structure of SYK in complex with compound 2 | monomer | 100 | 1×50J; 1×GOL; | |||
| SYK Kinase domain in complex with azabenzimidazole inhibitor 2b | monomer | 100.0 | 1×QFK; | |||
| Crystal structure of an inhibitor-bound Syk | monomer | 100.0 | 1×X4G; | |||
| Crystal structure of spleen tyrosine kinase complexed with 3-(8-{4-[Ethyl-(2-hydroxy-ethyl)-amino]-… | monomer | 100.0 | 1×0VE; | |||
| SYK Kinase domain in complex with diamine inhibitor 5 | monomer | 100.0 | 1×QFB; | |||
| Crystal structure of SYK kinase domain with N-(4-methyl-3-(8-methyl-7-oxo-2-(phenylamino)-7,8-dihyd… | monomer | 100.0 | 1×FPX; | |||
| Crystal structure of spleen tyrosine kinase complexed with r9021 | monomer | 100 | 1×0XF; | |||
| Crystal structure of an inhibitor-bound Syk | monomer | 100.0 | 1×X6G; | |||
| Crystal structure of spleen tyrosine kinase complexed with an adamantylpyrazine inhibitor | monomer | 100.0 | 1×0K1; | |||
| Crystal structure of spleen tyrosine kinase complexed with YM193306 | monomer | 100.0 | 1×P5C; | |||
| Crystal structure of an inhibitor-bound Syk | monomer | 100.0 | 1×X5G; | |||
| SYK Catalytic Domain Complexed with a Potent Triazine Inhibitor2 | monomer | 99.62 | 2×GOL; 1×3YX; | |||
| SYK catalytic domain in complex with a potent pyridopyrimidinone inhibitor | monomer | 99.62 | 1×2X6; | |||
| Crystal structure of an inhibitor-bound Syk | monomer | 100.0 | 1×X7G; | |||
| Crystal structure of ligand-free Syk | monomer | 100.0 | ||||
| Crystal structure of SYK kinase domain with 1-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-3-((1… | monomer | 100.0 | 1×FPU; | |||
| Crystal structure of spleen tyrosine kinase complexed with a 2-substituted 7-azaindole | monomer | 100.0 | 1×057; | |||
| Crystal structure of an inhibitor-bound Syk | monomer | 100.0 | 1×X3G; | |||
| Crystal Structure of Spleen Tyrosine Kinase Syk Catalytic Domain with Thienopyrazolylindole Inhibit… | monomer | 100.0 | 1×477; | |||
| CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A 2-(PHENOXYMETHYL)PYRIDINE INHIB… | monomer | 100.0 | 1×GDH; 3×BR; 1×GOL; 1×DMS; | |||
| Crystal structure of SYK kinase in complex with compound 1 | monomer | 100.0 | 1×A1H2Y; 2×GOL; | |||
| Crystal structure of tyrosine-protein kinase SYK with an inhibitor | monomer | 100.0 | 1×4MG; | |||
| Crystal structure of spleen tyrosine kinase (SYK) in complex with a diaminopyrimidine carboxamide i… | monomer | 100.0 | 1×S19; 3×GOL; | |||
| HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR | monomer | 100.0 | 1×6ZF; 5×GOL; | |||
| Crystal structure of spleen tyrosine kinase (Syk) in complex with GS-9973 | monomer | 100.0 | 1×CG9; | |||
| Crystal structures of spleen tyrosine kinase in complex with a novel inhibitor | monomer | 100.0 | 1×8OU; | |||
| SYK in COMPLEX WITH LIGAND LASW836 | monomer | 100.0 | 1×0SB; 1×SO4; | |||
| SYK kinase domain in complex with inhibitor GTC000225 | monomer | 100.0 | 1×4DJ; | |||
| SYK kinase domain in complex with inhibitor GTC000224 | monomer | 100.0 | 1×4DK; | |||
| HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR | monomer | 100.0 | 1×6ZG; 2×GOL; 1×DMS; | |||
| THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000233 | monomer | 100 | 1×GOL; 1×4DQ; | |||
| THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000222 | monomer | 100.0 | 1×4DF; 1×GOL; | |||
| Crystal structure of human SYK in complex with compound 24 | monomer | 100.0 | 1×A1H2W; 1×GOL; | |||
| THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000250 | monomer | 100.0 | 1×4DT; | |||
| THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000249 | monomer | 100.0 | 1×4DO; | |||
| The Crystal Structure of SYK from Biortus. | monomer | 100.0 | 1×3YT; 1×EDO; | |||
| Crystal structure of an inhibitor-bound Syk | monomer | 100.0 | 1×X8G; | |||
| Crystal structure of an inhibitor-bound Syk | monomer | 100.0 | 1×X9G; | |||
| THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000223 | monomer | 100.0 | 1×4DL; 1×DMS; | |||
| CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A 2-(PYRIDINYLOXYMETHYL)PYRIDINE … | monomer | 100.0 | 1×GDK; 1×GOL; | |||
| THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000226 | monomer | 100.0 | 1×4DN; | |||
| Crystal structure of Syk in complex with GS-9876 | monomer | 100.0 | 1×R6D; | |||
| Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyro… | monomer | 100.0 | 1×685; | |||
| The tandem SH2 domains of SYK | monomer | 100 | 1×PEG; 3×SCN; 1×CL; | |||
| Crystal structure of the apo SH2 domains of Syk | monomer | 100.0 | ||||
| SYK TYROSINE KINASE C-TERMINAL SH2 DOMAIN COMPLEXED WITH A PHOSPHOPEPTIDEFROM THE GAMMA CHAIN OF TH… | monomer | 99.04 | ||||
| SYK TYROSINE KINASE C-TERMINAL SH2 DOMAIN COMPLEXED WITH A PHOSPHOPEPTIDEFROM THE GAMMA CHAIN OF TH… | monomer | 99.04 | ||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4fl2.1.A | monomer | 0.78 | 1×MG; 1×ANP; | 100.00 | ||
| 1y57.1.A | monomer | 0.61 | 35.64 | |||
| 1opl.2.A | monomer | 0.60 | 38.16 | |||
| 4k11.1.A | monomer | 0.60 | 35.47 | |||
4 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 4fl2.1.A | monomer | 0.80 | 1×MG; 1×ANP; | 100.00 | ||
| Isoform 2 | 1y57.1.A | monomer | 0.65 | 35.11 | |||
| Isoform 2 | 1opl.2.A | monomer | 0.64 | 38.68 | |||
| Isoform 2 | 1opl.1.A | monomer | 0.64 | 38.68 | |||